Antibacterial immunity in respiratory tract: what role for the myeloid diffentiation primary response protein 88 (MyD88) adaptor?

被引:0
作者
Beze, Francois [1 ,2 ]
Chabe, Magali [1 ,3 ]
Delhaes, Laurence [1 ,2 ]
机构
[1] Univ Lille Nord France, Lab BDPEE, Ctr Infect & Immun Lille, INSERM,U1019,CNRS,Inst Pasteur Lille,UMR 8204, Lille, France
[2] CHRU Lille, Serv Parasitol Mycol, Lille, France
[3] Univ Lille Nord France, Lab Parasitol, Fac Pharm Lille, Lille, France
关键词
MyD88; innate immunity; antibacterial; adaptive immunity; respiratory mucosa; TOLL-LIKE RECEPTORS; NEGATIVE REGULATOR; INNATE IMMUNITY; MOUSE MODEL; ACTIVATION; CLEARANCE; FLAGELLIN; TOLL-LIKE-RECEPTOR-2; MICE;
D O I
10.1684/abc.2012.0697
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
As an essential interface between the external environment and the organism, the respiratory tract is particularly exposed to the potential injuries due to microorganisms, such as bacteria. Against these aggressions, the immune system has a key role, involving detection of germs followed by the establishment of innate and adaptive immune processes. During these responses, the adaptor protein MyD88 has a central place in the development of immune response: i) it contributes to innate immune response through the production of cytokines and chemokines, allowing recruitment and activation of effector cells; ii) it is involved secondarily in the development and orientation of antibacterial adaptive response, iii) and participates in sustaining immune homeostasis. Its importance is reflected in human pathology (MyD88 hereditary deficiency) by increasing susceptibility to few pathogenic bacteria responsible for respiratory infections which mainly occur in the upper respiratory tract. Since it has a key role, MyD88 is an essential factor for antibacterial immunity and more broadly for anti-infectious immunity. This protein might be therefore a possible therapeutic target.
引用
收藏
页码:245 / 250
页数:6
相关论文
共 50 条
  • [31] TH1 immune responses to fully MHC mismatched allografts are diminished in the absence of MyD88, a toll-like receptor signal adaptor protein
    Tesar, BM
    Zhang, JS
    Li, Q
    Goldstein, DR
    AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 (09) : 1429 - 1439
  • [32] Myeloid differentiation factor-88 (MyD88) is essential for control of primary in vivo Francisella tularensis LVS infection, but not for control of intramacrophage bacterial replication
    Collazo, Carmen M.
    Sher, Alan
    Meierovics, Anda I.
    Elkins, Karen L.
    MICROBES AND INFECTION, 2006, 8 (03) : 779 - 790
  • [33] Deficiency of the Myeloid Differentiation Primary Response Molecule MyD88 Leads to an Early and Rapid Development of Helicobacter-Induced Gastric Malignancy
    Banerjee, Anirban
    Thamphiwatana, Soracha
    Carmona, Ellese M.
    Rickman, Barry
    Doran, Kelly S.
    Obonyo, Marygorret
    INFECTION AND IMMUNITY, 2014, 82 (01) : 356 - 363
  • [34] Role of MyD88 signaling in the imiquimod-induced mouse model of psoriasis: focus on innate myeloid cells
    Costa, Sara
    Marini, Olivia
    Bevilacqua, Dalila
    DeFranco, Anthony L.
    Hou, Baidong
    Lonardi, Silvia
    Vermi, William
    Rodegher, Pamela
    Panato, Anna
    Tagliaro, Franco
    Lowell, Clifford A.
    Cassatella, Marco A.
    Girolomoni, Giampiero
    Scapini, Patrizia
    JOURNAL OF LEUKOCYTE BIOLOGY, 2017, 102 (03) : 791 - 803
  • [35] Mice Deficient in MyD88 Develop a Th2-Dominant Response and Severe Pathology in the Upper Genital Tract following Chlamydia muridarum Infection
    Chen, Lili
    Lei, Lei
    Chang, Xiaotong
    Li, Zhihong
    Lu, Chunxue
    Zhang, Xiaoyun
    Wu, Yimou
    Yeh, I-Tien
    Zhong, Guangming
    JOURNAL OF IMMUNOLOGY, 2010, 184 (05) : 2602 - 2610
  • [36] Scallop interferon regulatory factor 1 interacts with myeloid differentiation primary response protein 88 and is crucial for antiviral innate immunity
    Liu, Wenjuan
    Li, Fangshu
    Ma, Jilv
    Chen, Jiwen
    Huang, Baoyu
    Li, Lingling
    Fan, Nini
    Wang, Xiaomei
    Zheng, Yanxin
    Wang, Xiaona
    Wei, InvestigationResourcesLei
    Liu, Yaqiong
    Zhang, Meiwei
    Liu, Fengchen
    Qi, Yitao
    Wang, Xiaotong
    INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2022, 222 : 1250 - 1263
  • [37] Targeted deletion of MyD88 in intestinal epithelial cells results in compromised antibacterial immunity associated with downregulation of polymeric immunoglobulin receptor, mucin-2, and antibacterial peptides
    Frantz, A. L.
    Rogier, E. W.
    Weber, C. R.
    Shen, L.
    Cohen, D. A.
    Fenton, L. A.
    Bruno, M. E. C.
    Kaetzel, C. S.
    MUCOSAL IMMUNOLOGY, 2012, 5 (05) : 501 - 512
  • [38] Myeloid differentiation protein 2 silencing decreases LPS-induced cytokine production and TLR4/MyD88 pathway activity in alveolar macrophages
    Ren, Weiying
    Hu, Lijuan
    Hua, Feng
    Jin, Jianjun
    Wang, Yanying
    Zhu, Lei
    IMMUNOLOGY LETTERS, 2011, 141 (01) : 94 - 101
  • [39] A Yersinia ruckeri TIR Domain-Containing Protein (STIR-2) Mediates Immune Evasion by Targeting the MyD88 Adaptor
    Liu, Tao
    Wei, Wen-Yan
    Wang, Kai-Yu
    Wang, Er-Long
    Yang, Qian
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (18)
  • [40] Expression patterns of Toll like receptor (TLR)-2, TLR-4 and myeloid differentiation primary response gene 88 (MYD88) in renal transplant patients developing allograft dysfunction; a cohort study
    Hosseinzadeh, Morteza
    Ahmadpoor, Pedram
    Yekaninejad, Mir Saeed
    Pourrezagholi, Fatemeh
    Foroughi, Farshad
    Ghorbanpour, Mina
    Barabadi, Mehri
    Shahbaz, Sanaz K.
    Solgi, Ghasem
    Amirzargar, Aliakbar
    TRANSPLANT IMMUNOLOGY, 2018, 48 : 26 - 31